FGF and ROR2 receptor tyrosine kinase signaling in human skeletal development

Sigmar Stricker1, Stefan Mundlos

  • 1Development and Disease Group, Max Planck-Institute for Molecular Genetics, Berlin, Germany.

Insights

Skeletal malformations are common human developmental issues. This review details the roles of fibroblast growth factor receptors (FGFRs) and ROR2 tyrosine kinase in skeletal development and disease.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Genetics

Background:

  • Skeletal malformations are frequent human developmental disturbances.
  • Receptor tyrosine kinases are crucial for embryonic development.
  • Fibroblast growth factor receptors (FGFRs) and ROR2 are key players in skeletal formation.

Purpose of the Study:

  • To review the involvement of FGFR signaling in human skeletal diseases.
  • To provide an update on the knowledge of ROR2 in skeletal development.

Main Methods:

  • Review of scientific literature.
  • Analysis of animal models for skeletal development.
  • Identification of mutations causing human skeletal syndromes.

Main Results:

  • FGFR signaling is critical for cranial, axial, and appendicular bone formation.
  • ROR2 tyrosine kinase has a complex and significant role in skeletal development.

Conclusions:

  • Understanding FGFR and ROR2 pathways is vital for addressing skeletal malformations.
  • Further research into these receptor tyrosine kinases will advance the treatment of skeletal disorders.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...